SE9702305D0 - New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives - Google Patents
New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivativesInfo
- Publication number
- SE9702305D0 SE9702305D0 SE9702305A SE9702305A SE9702305D0 SE 9702305 D0 SE9702305 D0 SE 9702305D0 SE 9702305 A SE9702305 A SE 9702305A SE 9702305 A SE9702305 A SE 9702305A SE 9702305 D0 SE9702305 D0 SE 9702305D0
- Authority
- SE
- Sweden
- Prior art keywords
- oxazolidinedione
- oxadiazolidinedione
- derivatives
- thiazolidinedione
- new thiazolidinedione
- Prior art date
Links
- ZOBPZXTWZATXDG-UHFFFAOYSA-N 1,3-thiazolidine-2,4-dione Chemical compound O=C1CSC(=O)N1 ZOBPZXTWZATXDG-UHFFFAOYSA-N 0.000 title abstract 2
- 229940123464 Thiazolidinedione Drugs 0.000 title abstract 2
- YDCVQGAUCOROHB-UHFFFAOYSA-N oxadiazolidine-4,5-dione Chemical class O=C1NNOC1=O YDCVQGAUCOROHB-UHFFFAOYSA-N 0.000 title abstract 2
- COWNFYYYZFRNOY-UHFFFAOYSA-N oxazolidinedione Chemical compound O=C1COC(=O)N1 COWNFYYYZFRNOY-UHFFFAOYSA-N 0.000 title abstract 2
- 206010022489 Insulin Resistance Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/44—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702305A SE9702305D0 (sv) | 1997-06-17 | 1997-06-17 | New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives |
| ZA984795A ZA984795B (en) | 1997-06-17 | 1998-06-03 | New thiazolidinedione oxazolidinedione and oxadiazolidinedione derivatives |
| JP50425699A JP2002503255A (ja) | 1997-06-17 | 1998-06-04 | 新しいチアゾリジンジオン、オキサゾリジンジオンおよびオキサジアゾリジンジオン誘導体 |
| NZ501428A NZ501428A (en) | 1997-06-17 | 1998-06-04 | Thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives useful for conditions such as insulin resistance |
| EP98928757A EP0991632A1 (en) | 1997-06-17 | 1998-06-04 | New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives |
| ARP980102644A AR012924A1 (es) | 1997-06-17 | 1998-06-04 | Derivados de tiazolidindiona, oxazolidindiona y oxadiazolidindiona, proceso para su preparacion, composiciones y formulaciones farmaceuticas, usode dichos compuestos para la fabricacion de formulaciones y metodo de tratamiento |
| AU80475/98A AU732105B2 (en) | 1997-06-17 | 1998-06-04 | New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives |
| PCT/SE1998/001066 WO1998057941A1 (en) | 1997-06-17 | 1998-06-04 | New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives |
| CA002293449A CA2293449A1 (en) | 1997-06-17 | 1998-06-04 | New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives |
| US09/091,875 US6288096B1 (en) | 1997-06-17 | 1998-06-04 | Thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702305A SE9702305D0 (sv) | 1997-06-17 | 1997-06-17 | New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE9702305D0 true SE9702305D0 (sv) | 1997-06-17 |
Family
ID=20407407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9702305A SE9702305D0 (sv) | 1997-06-17 | 1997-06-17 | New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6288096B1 (sv) |
| EP (1) | EP0991632A1 (sv) |
| JP (1) | JP2002503255A (sv) |
| AR (1) | AR012924A1 (sv) |
| AU (1) | AU732105B2 (sv) |
| CA (1) | CA2293449A1 (sv) |
| NZ (1) | NZ501428A (sv) |
| SE (1) | SE9702305D0 (sv) |
| WO (1) | WO1998057941A1 (sv) |
| ZA (1) | ZA984795B (sv) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9801990D0 (sv) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl propionic acid derivatives and analogs |
| US7232828B2 (en) | 2002-08-10 | 2007-06-19 | Bethesda Pharmaceuticals, Inc. | PPAR Ligands that do not cause fluid retention, edema or congestive heart failure |
| CN1812988A (zh) * | 2003-05-13 | 2006-08-02 | 斯索恩有限公司 | 制备噻唑烷二酮衍生物的方法及其化合物 |
| US7230016B2 (en) * | 2003-05-13 | 2007-06-12 | Synthon Ip Inc. | Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same |
| EP1716144A2 (en) * | 2004-02-20 | 2006-11-02 | Synthon B.V. | Processes for making pioglitazone and compounds of the processes |
| US7161756B2 (en) * | 2004-05-10 | 2007-01-09 | Tandberg Data Storage Asa | Method and system for communication between a tape drive and an external device |
| US7833513B2 (en) | 2004-12-03 | 2010-11-16 | Rhode Island Hospital | Treatment of Alzheimer's Disease |
| WO2006138328A1 (en) * | 2005-06-14 | 2006-12-28 | Merck & Co., Inc. | Process for the production of antidiabetic oxazolidinediones |
| TW200815377A (en) * | 2006-04-24 | 2008-04-01 | Astellas Pharma Inc | Oxadiazolidinedione compound |
| ES2830073T3 (es) | 2007-04-11 | 2021-06-02 | Omeros Corp | Composiciones y métodos para la profilaxis y el tratamiento de adicciones |
| US11241420B2 (en) | 2007-04-11 | 2022-02-08 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| US20160331729A9 (en) | 2007-04-11 | 2016-11-17 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| CN103153972A (zh) * | 2010-04-19 | 2013-06-12 | 新陈代谢解决方案开发公司 | 噻唑烷二酮化合物的新的合成方法 |
| MX2012012092A (es) | 2010-04-19 | 2012-12-17 | Metabolic Solutions Dev Co Llc | Sintesis novedosa para compuestos de tiazolidinadiona. |
| HUE031424T2 (en) | 2010-08-10 | 2017-07-28 | Octeta Therapeutics Llc | New synthesis of thiazolidinedione compounds |
| HUE029488T2 (en) | 2010-08-10 | 2017-02-28 | Metabolic Solutions Dev Co Llc | Synthesis of Thiazolidinedione Compounds |
| KR101890959B1 (ko) | 2010-11-04 | 2018-08-22 | 알비레오 에이비 | 간질환 치료를 위한 ｉｂａｔ 억제제 |
| CN103228270B (zh) | 2010-11-08 | 2016-02-10 | 阿尔比里奥公司 | 含ibat抑制剂和胆汁酸结合剂的药物组合 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
| JPS6051189A (ja) | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
| US5223522A (en) * | 1988-03-08 | 1993-06-29 | Pfizer Inc. | Thiazolidinedione hypoglycemic agents |
-
1997
- 1997-06-17 SE SE9702305A patent/SE9702305D0/sv unknown
-
1998
- 1998-06-03 ZA ZA984795A patent/ZA984795B/xx unknown
- 1998-06-04 NZ NZ501428A patent/NZ501428A/en unknown
- 1998-06-04 AU AU80475/98A patent/AU732105B2/en not_active Ceased
- 1998-06-04 EP EP98928757A patent/EP0991632A1/en not_active Withdrawn
- 1998-06-04 AR ARP980102644A patent/AR012924A1/es unknown
- 1998-06-04 JP JP50425699A patent/JP2002503255A/ja active Pending
- 1998-06-04 CA CA002293449A patent/CA2293449A1/en not_active Abandoned
- 1998-06-04 WO PCT/SE1998/001066 patent/WO1998057941A1/en not_active Ceased
- 1998-06-04 US US09/091,875 patent/US6288096B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU732105B2 (en) | 2001-04-12 |
| ZA984795B (en) | 1999-01-04 |
| US6288096B1 (en) | 2001-09-11 |
| WO1998057941A1 (en) | 1998-12-23 |
| JP2002503255A (ja) | 2002-01-29 |
| CA2293449A1 (en) | 1998-12-23 |
| AU8047598A (en) | 1999-01-04 |
| AR012924A1 (es) | 2000-11-22 |
| NZ501428A (en) | 2001-05-25 |
| EP0991632A1 (en) | 2000-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9801992D0 (sv) | New 3-aryl-2-hydroxypropionic acid derivative I | |
| SE9702305D0 (sv) | New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives | |
| MY129581A (en) | New 3-aryl propionic acid derivatives and analogs | |
| ATE109145T1 (de) | Heterozyklische acylaminothiazolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| NO303782B1 (no) | Tiazolidin- og oksazolidinderivater og farmas°ytiske preparater inneholdende slike, samt deres anvendelse til fremstilling av medikamenter | |
| FI873162A0 (fi) | Foerfarande foer framstaellning av proteiner med faktor viii aktivitet med mikrobiala vaerdceller; expressionsvektorer, vaerdceller och antikroppar. | |
| DE3750431D1 (de) | Stabilisiertes Arzneimittel und dessen Herstellung. | |
| FI940378A0 (sv) | 5-ledade heterocykler, förfarande för deras framställning och dessa föreningar innehållande läkemedel | |
| AU649421B2 (en) | Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs | |
| ZA975866B (en) | Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases. | |
| ATE297935T1 (de) | 2-(iminomethyl)aminophenyl-derivate, deren herstellung, verwendung als medikamente und diese enthaltende pharmazeutische zubereitungen | |
| DE3580616D1 (de) | Mitomycinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| NO20002835L (no) | 2-aryl-oksodihydropurinderivater, fremgangsmÕte for fremstilling av disse medisinske preparater inneholdende disse, og mellomprodukter derfor | |
| DE69931925D1 (de) | 2-chinolonen enthaltende arzneimittel | |
| DE69815094D1 (de) | 2-(iminoethyl)-aminophenyl - derivate, deren herstellung, deren verwendung als medikamente und diese enthaltende pharmazeutische zubereitungen | |
| CO4290432A1 (es) | Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos. | |
| FI940904A7 (sv) | Oxazolidindionderivat, deras framställning och användning | |
| NO305657B1 (no) | 4-substituerte piperidinderivater og farmas°ytisk preparat derav | |
| ATE231872T1 (de) | Thiazolopyrimidinderivate | |
| DE59905572D1 (de) | Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate | |
| DE3877406D1 (de) | Benzothiazolinon-derivate, ihre herstellung und pharmazeutische zusammensetzung. | |
| FI972308A0 (sv) | 2-substituerade 1,2,5-tiadiazolidin-3-oni-1,1-dioxider och dessa innehållande kompositioner och förfarande för deras användning | |
| DE68900210D1 (de) | Pyranobenzoxadiazolderivate, herstellung, verwendung und diese enthaltende zubereitungen. | |
| AU6242190A (en) | New thiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same | |
| DE59811437D1 (de) | Oxiranyl-triazolinthione und ihre verwendung als mikrobizide |